2.92%
12.62%
15.13%
8.52%
12.73%
8.66%
79.40%
AI Spotlight on A
Company Description
Agilent Technologies, Inc.provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics.The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services.
The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.Agilent Technologies, Inc.was incorporated in 1999 and is headquartered in Santa Clara, California.
Market Data
| Last Price | 151.38 |
| Change Percentage | 2.92% |
| Open | 148.95 |
| Previous Close | 147.09 |
| Market Cap ( Millions) | 43233 |
| Volume | 1496040 |
| Year High | 155.35 |
| Year Low | 124.16 |
| M A 50 | 138.68 |
| M A 200 | 138.17 |
Financial Ratios
| FCF Yield | 3.18% |
| Dividend Yield | 0.63% |
| ROE | 21.30% |
| Debt / Equity | 57.48% |
| Net Debt / EBIDTA | 118.93% |
| Price To Book | 7.38 |
| Price Earnings Ratio | 33.79 |
| Price To FCF | 31.49 |
| Price To sales | 6.64 |
| EV / EBITDA | 26.14 |
News
- Jan -24 - Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
- Jan -24 - Agilent Automated Workflows at SLAS2025: Connecting with Confidence
- Jan -16 - Agilent Rises 11% in a Year: Should You Buy, Sell or Hold the Stock?
- Jan -15 - Agilent Technologies, Inc. (A) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)
- Dec -30 - Reaves Utility Income Fund Section 19(A) Notice
- Dec -23 - Is the Options Market Predicting a Spike in Agilent (A) Stock?
- Dec -19 - Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Dec -17 - Agilent investor day calls for margin expansion, says Goldman Sachs
- Dec -17 - Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics
- Dec -10 - Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
- Dec -09 - Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?
- Dec -02 - International Markets and Agilent (A): A Deep Dive for Investors
- Nov -26 - Agilent Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
- Nov -26 - Agilent Q4: Expecting Market Recovery In 2025
- Nov -26 - Agilent Technologies, Inc. (A) Q4 2024 Earnings Call Transcript
- Nov -26 - Agilent (A) Reports Q4 Earnings: What Key Metrics Have to Say
- Nov -25 - Dow and Small-Caps Close at New All-Time Highs
- Nov -25 - Agilent Technologies (A) Beats Q4 Earnings and Revenue Estimates
- Nov -25 - Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat
- Nov -25 - Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Life Sciences and Applied Markets
Expected Growth : 3.5 %
What the company do ?
Life Sciences and Applied Markets from Agilent Technologies, Inc. provides instruments, software, and services for pharmaceutical, biotechnology, and academic research, as well as applied markets such as food, environmental, and forensic testing.
Why we expect these perspectives ?
Agilent's Life Sciences and Applied Markets segment growth is driven by increasing demand for biopharmaceuticals, precision medicine, and applied genomics. The segment benefits from the company's strong portfolio of instruments, software, and services, as well as its leadership in emerging markets such as China and India. Additionally, the segment's growth is fueled by the increasing adoption of digital technologies, such as artificial intelligence and machine learning, in life sciences research and development.
Segment n°2 -> Agilent CrossLab
Expected Growth : 3.8 %
What the company do ?
Agilent CrossLab is a suite of cloud-based lab management software and services for life sciences and applied markets, integrating instrument control, data management, and collaboration tools.
Why we expect these perspectives ?
Agilent CrossLab's 3.8% growth is driven by increasing demand for lab workflow optimization, expansion in biopharma and contract research organizations, and growing adoption of digital lab solutions. Additionally, Agilent's strategic acquisitions and partnerships have enhanced its offerings, contributing to the segment's growth.
Segment n°3 -> Diagnostics and Genomics
Expected Growth : 4.2 %
What the company do ?
Diagnostics and Genomics from Agilent Technologies, Inc. provides solutions for genetic analysis, enabling researchers to identify genetic variations and develop targeted therapies.
Why we expect these perspectives ?
Agilent's Diagnostics and Genomics segment growth of 4.2% is driven by increasing demand for precision medicine, adoption of next-generation sequencing (NGS) technologies, and expansion in emerging markets. Additionally, the segment benefits from growing awareness of genetic testing, increasing research and development activities, and strategic partnerships and collaborations.
Agilent Technologies, Inc. Products
| Product Range | What is it ? |
|---|---|
| Life Sciences and Applied Markets | Provides instruments, software, and services for life sciences, diagnostics, and applied markets |
| Agilent CrossLab | Offers a range of laboratory supplies, including instruments, consumables, and services |
| Mass Spectrometry | Provides mass spectrometry instruments and software for life sciences, pharmaceutical, and applied markets |
| Chromatography and Spectroscopy | Offers a range of chromatography and spectroscopy instruments and software for life sciences and applied markets |
| Diagnostics and Genomics | Provides instruments, software, and services for molecular diagnostics, genomics, and pathology |
| Electronic Measurement | Offers a range of electronic measurement instruments and software for aerospace, defense, and industrial markets |
Agilent Technologies, Inc.'s Porter Forces
Threat Of Substitutes
Agilent Technologies, Inc. faces moderate threat from substitutes due to the availability of alternative products and services in the life sciences and applied markets.
Bargaining Power Of Customers
Agilent Technologies, Inc. has a diverse customer base, which reduces the bargaining power of individual customers, giving the company an upper hand in negotiations.
Bargaining Power Of Suppliers
Agilent Technologies, Inc. relies on a few key suppliers for critical components, giving them some bargaining power, but the company's size and scale mitigate this risk.
Threat Of New Entrants
The life sciences and applied markets have high barriers to entry, including significant R&D investments and regulatory hurdles, making it difficult for new entrants to challenge Agilent Technologies, Inc.'s position.
Intensity Of Rivalry
The life sciences and applied markets are highly competitive, with several established players competing for market share, driving innovation, and pricing pressure.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 32.24% |
| Debt Cost | 3.95% |
| Equity Weight | 67.76% |
| Equity Cost | 9.41% |
| WACC | 7.65% |
| Leverage | 47.58% |
Agilent Technologies, Inc. : Quality Control
Agilent Technologies, Inc. passed 8 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| IQV | IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: … |
| MTD | Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and … |
| IDXX | IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; … |
| TMO | Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences … |
| DHR | Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Mettler-Toledo
A-Score
1-Year Total Return ->
🥈
Thermo Fisher
A-Score
1-Year Total Return ->
🥉
Danaher
A-Score
1-Year Total Return ->
4
Agilent Technologies
A-Score
1-Year Total Return ->
5
IQVIA
A-Score
1-Year Total Return ->
6
